Core Insights - Rocket Doctor AI Inc. reported its first significant revenue quarter in Q2 2025, generating $0.5 million, primarily due to the acquisition of Rocket Doctor Inc. [5][6] - The company completed the acquisition of Rocket Doctor Inc. on April 10, 2025, enhancing its digital health platform and expanding its operational capabilities [4][12] - The company is focusing on U.S. expansion and has secured new contracts, including a virtual-care partnership with Central California Alliance for Health, serving approximately 450,000 members [5][23] Financial Highlights - Q2 2025 revenue was $0.5 million, compared to $0 in Q1 2025 and Q2 2024, marking a significant increase attributed to the Rocket Doctor acquisition [6] - Gross margin for Q2 2025 was 89%, a notable improvement from 0% in previous quarters, driven by revenue from the digital health platform [6][27] - The net comprehensive loss for Q2 2025 was $2.7 million, or $0.04 per share, consistent with the loss reported in Q1 2025 but an improvement from $2.7 million or $0.07 per share in Q2 2024 [6][27] Corporate Developments - The company has shifted its business model from B2C to B2B, aligning with the demand for AI-driven solutions in healthcare systems and academic institutions [8] - The Global Library of Medicine (GLM) is central to the company's strategy, providing clinical decision support and educational tools [7][21] - The company has made significant investments in enhancing its platform architecture and API capabilities, positioning itself for accelerated commercialization [24] Market Opportunity - The global AI healthcare market is projected to exceed USD $180 billion by 2030, driven by the demand for efficiency and accuracy in clinical workflows [9] - The conversational AI segment is expected to grow from approximately USD $13.5 billion in 2024 to between USD $49 billion and $123 billion by 2030, indicating a ~24% CAGR [9] Product Development - The Medical Education Suite (MES) was successfully deployed to 240 medical students at the University of Minnesota, showcasing the potential of AI-driven tools in medical education [15][24] - Rocket Doctor's technology solutions, including Starship EMR and RD Connect, are designed to streamline workflows and reduce care delivery costs [12][19] - The company is actively developing an AI Pharmacy Assistant, with integration plans involving over 20 pharmacies [18]

Core Insights - Treatment.com AI Inc. has successfully completed the acquisition of Rocket Doctor, enhancing its mission to integrate AI with virtual healthcare delivery [2][9] - The acquisition has led to significant growth in patient volume and physician adoption for Rocket Doctor, indicating strong market demand [3][9] Company Achievements - Rocket Doctor reported a 112% year-over-year increase in patient volume in Alberta, with 36,779 patients seen in the past year [3][9] - The platform has served over 71,000 Albertans, with 35% of patients from communities with populations under 25,000, highlighting its role in underserved areas [3] - Physician adoption increased by 218%, from 22 active physicians last year to 70 this year, allowing for rapid scaling [3] Product Development - Treatment.com AI launched a new generation of the Medical Education Suite (MES) at the University of Minnesota Medical School, featuring AI-simulated patients for assessing third-year medical students [4] - The MES has the potential to reduce exam administration costs by approximately 40% and decrease faculty workload [4] Partnerships and Collaborations - Rocket Doctor initiated a virtual care program in California with Central California Alliance for Health, serving around 450,000 members [5] - In Canada, Rocket Doctor partnered with Melanoma Canada to enhance follow-up care for high-risk skin cancer patients in Ontario, Alberta, and British Columbia [6] Recognition and Awards - Rocket Doctor was named Top Clinical Innovator by the American Telemedicine Association at the NEXUS2025 conference, recognizing its physician-led virtual care model [7][9] - The company has been invited to participate in prestigious accelerators and thought leadership programs, including the UC Berkeley Health Engine Accelerator and AARP's AgeTech Accelerator [8][9] Leadership and Insights - Dr. William Cherniak, CEO of Rocket Doctor, emphasized the transformational period for both companies, focusing on a shared vision and execution across various healthcare fronts [12] - A peer-reviewed research paper co-authored by Dr. Cherniak and other physicians provides insights into patient behavior and the role of digital tools in enhancing health equity [11]

Core Insights - Treatment.com AI Inc. has launched its latest Medical Education Suite (MES), an AI-powered platform for clinical skills assessment, successfully deployed at the University of Minnesota Medical School [1][5] - The MES aims to enhance the delivery and evaluation of Objective Structured Clinical Examinations (OSCEs) by providing scalable, rigorous, and cost-effective solutions [1][5] Group 1: Deployment and Implementation - The MES was deployed with over 240 third-year medical students, marking the first large-scale implementation of computer-simulated patient cases developed through the Global Library of Medicine (GLM) [2][5] - The deployment demonstrated complete technical reliability and seamless integration into the existing OSCE workflow at the University of Minnesota [2][6] Group 2: Features and Benefits - The MES incorporates AI-simulated patients and real-time scoring, which supports faster, accurate, and objective assessments, potentially leading to approximately 40% cost savings for the University of Minnesota [5][6] - The platform is designed to reduce faculty preparation and administrative workload while providing objective evaluations aligned with clinical learning objectives [6][8] Group 3: Educational Impact - Early feedback indicates that the MES enhances the student learning experience and strengthens the reliability of OSCE results, helping students build stronger clinical skills [4][6] - The platform combines AI-simulated patients with automated feedback, allowing faculty to assess various competencies such as diagnostic reasoning and clinical prioritization [4][6] Group 4: Future Prospects - Treatment.com AI is engaging with various medical schools to extend the MES offering across North America, the UK, and other international OSCE markets [8] - Preliminary results of the MES's accuracy and precision were presented at the AAMC's 2025 Group on Information Resources meeting, with further scientific publications planned [7]

Core Insights - Treatment.com AI Inc. has launched its latest Medical Education Suite (MES), an AI-powered platform aimed at enhancing clinical skills assessment in medical education [1][7] - The University of Minnesota Medical School has successfully deployed the MES with over 240 third-year medical students, marking a significant step in the integration of AI in medical training [2][4] Company Overview - Treatment.com AI utilizes artificial intelligence and clinical expertise to address inefficiencies in the healthcare sector, developing the Global Library of Medicine (GLM) to support healthcare professionals [9] - The MES is designed to provide scalable, rigorous, and cost-effective Objective Structured Clinical Examinations (OSCEs), improving the educational experience for medical students [1][3] Deployment and Features - The MES was implemented seamlessly into the University of Minnesota's existing OSCE workflow, demonstrating complete technical reliability during deployment [2][4] - Key features of the MES include AI-simulated patients, real-time scoring, and automated feedback, which enhance the objectivity and consistency of student evaluations [4][8] Cost Efficiency - The University of Minnesota reported approximately 40% cost savings in administrative expenses due to the implementation of the MES [8][7] - The platform aims to reduce faculty preparation and administrative workload while aligning evaluations with clinical learning objectives [8][4] Future Prospects - Treatment.com AI is actively engaging with various educational institutions to expand the MES offering across North America, the UK, and other international markets [6][7] - Preliminary results regarding the accuracy and precision of the GLM as applied in the MES were presented at the AAMC's 2025 Group on Information Resources meeting, with further scientific publications in preparation [5][7]